Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | -0.02% | 477.94 | 1.0% | $753.43m | |
| DHR | Danaher Corp. | -0.06% | 237.15 | 0.7% | $651.68m | |
| MDT | Medtronic Plc | -0.01% | 123.89 | 0.6% | $614.52m | |
| ABT | Abbott Laboratories | 0.87% | 122.49 | 0.8% | $606.50m | |
| ALGN | Align Technology, Inc. | 0.00% | 594.93 | 6.3% | $358.42m | |
| ISRG | Intuitive Surgical, Inc. | 0.00% | 785.83 | 2.3% | $347.03m | |
| SYK | Stryker Corp. | -0.02% | 252.25 | 1.3% | $298.93m | |
| NVCR | NovoCure Ltd. | 0.00% | 186.00 | 6.8% | $279.45m | |
| DXCM | DexCom, Inc. | 0.00% | 391.10 | 7.8% | $277.48m | |
| BDX | Becton, Dickinson & Co. | 0.12% | 250.11 | 1.0% | $275.09m | |
| BSX | Boston Scientific Corp. | -0.03% | 39.66 | 1.0% | $244.85m | |
| IDXX | IDEXX Laboratories, Inc. | 0.00% | 514.16 | 3.7% | $223.91m | |
| BAX | Baxter International, Inc. | 0.07% | 84.70 | 1.8% | $220.94m | |
| EW | Edwards Lifesciences Corp. | -0.04% | 86.22 | 0.4% | $220.84m | |
| A | Agilent Technologies, Inc. | -0.08% | 131.87 | 1.6% | $187.81m |
Company Profile
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.